Table 3

OR for treatment initiation of secondary prevention drugs within 30 days after myocardial infarction associated with rheumatoid arthritis and effects of successive inclusion of covariates

Aspirinβ-BlockersClopidogrelRAS blockersStatins
OR (CI)OR (CI)OR (CI)OR (CI)OR (CI)
Included covariates
Sex and age0.76 (0.64 to 0.90)0.74 (0.63 to 0.88)0.85 (0.73 to 0.98)0.78 (0.60 to 1.02)0.66 (0.55 to 0.78)
Socio-economic status0.76 (0.64 to 0.91)0.75 (0.63 to 0.89)0.85 (0.73 to 0.99)0.78 (0.60 to 1.02)0.66 (0.56 to 0.79)
Comorbidity0.80 (0.67 to 0.96)0.77 (0.65 to 0.92)0.88 (0.75 to 1.02)0.80 (0.61 to 1.05)0.69 (0.58 to 0.82)
  • RAS, renin angiotensin system.